DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rebetol (Ribavirin) - Decreased Appetite - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Decreased Appetite (115)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rebetol (Ribavirin) where reactions include decreased appetite. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 115   Next >>

Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: White Blood Cell Count Decreased, Renal Impairment, Anaemia, Platelet Count Decreased, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 mcg /kg/week
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-04-25

PEG-Intron
    Dosage: 1.0 mcg /kg/week
    Start date: 2012-06-26

PEG-Intron
    Dosage: 1.0 mcg /kg/week
    Start date: 2012-04-26
    End date: 2012-06-06

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-06-06

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-06-07

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-06-26
    End date: 2012-07-24

Other drugs received by patient: Motilium; Lorfenamin; Motilium; L Cartin; Rikkunshi-TO; Epadel



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-27

Patient:

Reactions: Anaemia, Blood Uric Acid Increased, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 30 microgram per kilogram, qw
    Start date: 2012-07-05

PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-06-21

PEG-Intron
    Dosage: 50 microgram per kilogram, qw
    Start date: 2012-07-12

PEG-Intron
    Dosage: 70 microgram per kilogram, qw
    Start date: 2012-07-19

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-06-27

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-07-05

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-14
    End date: 2012-06-27

Other drugs received by patient: Theo-DUR; Lendormin; Mucodyne



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Malaise, Renal Impairment, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, unk
    Indication: Hepatitis C
    Start date: 2012-06-06

Rebetol
    Dosage: 600 mg, unk
    Administration route: Oral
    Start date: 2012-06-15
    End date: 2012-06-20

Rebetol
    Dosage: 200 mg, unk
    Administration route: Oral
    Start date: 2012-06-21
    End date: 2012-07-12

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-06
    End date: 2012-06-14

Rebetol
    Dosage: 200 mg, qod
    Administration route: Oral
    Start date: 2012-07-13

Telavic
    Dosage: 1500 mg, unk
    Administration route: Oral
    Start date: 2012-06-08

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-06
    End date: 2012-06-07

Other drugs received by patient: Lendormin; Lansoprazole; Amoban



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-27

Patient:

Reactions: Drug Eruption, Haemoglobin Decreased, Malaise, Hyperglycaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-17

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-06-13

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-14
    End date: 2012-06-28

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-07-18
    End date: 2012-07-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-05-25

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral

Other drugs received by patient: Motilium; Gasmotin; Diflorasone Diacetate; Nizatidine



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-25

Patient:

Reactions: Fatigue, Pruritus, Rash, Drug Abuse, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-05

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-05



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-25

Patient:

Reactions: Stomatitis, Fatigue, DRY Mouth, Decreased Appetite

Drug(s) suspected as cause:
Pegasys
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-19

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-19

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-22

Other drugs received by patient: Gabapentin; Metformin HCL; Levothyroxine Sodium; Acyclovir; Lisinopril; Levetiracetam



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-08-24

Patient:

Reactions: Weight Decreased, Tongue Disorder, Anaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-04-24
    End date: 2012-01-01

PEG-Intron
    Dosage: 120 microgram, qw
    Start date: 2012-01-01

Rebetol
    Dosage: 2x 200 mg in the morning and 200 mg in the evening
    Start date: 2012-08-09

Rebetol
    Dosage: unk unk, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-24
    End date: 2012-01-01

Rebetol
    Dosage: 600 mg in the morning and 400 mg in the evening
    Administration route: Oral
    Start date: 2012-01-01
    End date: 2012-08-08

Other drugs received by patient: Vasexten; Januvia; Valsartan and Hydrochlorothiazide; Glucophage; Nobiten



Possible Rebetol side effects in 67 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24

Patient: 67 year old male

Reactions: Nausea, Neutrophil Count Decreased, Erythema, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Pegintron / 01543001 /
    Dosage: 1.5 a?g/kg, unk
    Indication: Hepatitis C
    Start date: 2012-02-24
    End date: 2012-06-12

Rebetol
    Dosage: 400 mg, unk
    Administration route: Oral
    Start date: 2012-03-27
    End date: 2012-06-03

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-24
    End date: 2012-02-28

Rebetol
    Dosage: 800 mg, unk
    Administration route: Oral
    Start date: 2012-03-02
    End date: 2012-03-26

Rebetol
    Dosage: 400 unk, unk
    Administration route: Oral
    End date: 2012-06-19

VX-950
    Dosage: 2250 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-24
    End date: 2012-02-28

Other drugs received by patient: Loxonin; Lansoprazole; Lansoprazole; Doxazosin Mesylate; Petrolatum Salicylate; Norvasc; Loxonin; Antebate Ointment; Aspirin; Diovan; Humalog; Lasix; Primperan TAB



Possible Rebetol side effects in

Reported by a individual with unspecified qualification from Japan on 2012-08-24

Patient:

Reactions: Deafness, Dizziness, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-26
    End date: 2012-02-14

Antiviral (Unspecified)
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-02-21
    End date: 2012-03-07

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Start date: 2012-02-23
    End date: 2012-03-01

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-01-26
    End date: 2012-02-09

Peginterferon Alfa-2B
    Dosage: 1.5 microgram per kilogram, qw
    Start date: 2012-02-23
    End date: 2012-03-01

Peginterferon Alfa-2B
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-01-26
    End date: 2012-02-09

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-02-09
    End date: 2012-03-07

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-26
    End date: 2012-02-08

Telavic
    Dosage: 1500 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-26
    End date: 2012-02-14

Telavic
    Dosage: 750 mg, once
    Administration route: Oral
    Start date: 2012-02-21
    End date: 2012-03-07

Other drugs received by patient: Diovan; Rebamipide; Urso 250; Proheparum; Nifedipine CR Sawai; Primperan TAB; Famotidine; Famotidine; Loxoprofen; Loxoprofen; Valsartan and Hydrochlorothiazide; Diovan; Primperan TAB; Rebamipide; Famotidine; Famotidine; Glycyron; Sepamit



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.0mcg/kg/week
    Start date: 2012-06-14

PEG-Intron
    Dosage: 1.2mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-16
    End date: 2012-05-30

PEG-Intron
    Dosage: 0.5mcg/kg/week
    Start date: 2012-06-07
    End date: 2012-06-07

Rebetol
    Administration route: Oral
    Start date: 2012-05-16
    End date: 2012-07-11

Rebetol
    Administration route: Oral
    Start date: 2012-07-12
    End date: 2012-07-17

Rebetol
    Dosage: 800 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-05-16
    End date: 2011-07-11

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-07-19

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-07-12

Telavic
    Dosage: 1500 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-16

Other drugs received by patient: Merislon; Glufast; Calblock; Solacet F; Glufast; Merislon; Loxonin; Talion (Bepotastine Besylate); Vitamedin; Calblock; Lansoprazole; [therapy Unspecified]; Methaderm Creme



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Drug Eruption, Haemoglobin Decreased, Malaise, Hyperglycaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-17

Rebetol
    Administration route: Oral

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-06-13

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-14
    End date: 2012-06-28

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-17
    End date: 2012-05-25

Telavic
    Dosage: 1500 mg, once
    Administration route: Oral
    Start date: 2012-07-18
    End date: 2012-07-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral

Other drugs received by patient: Gasmotin; Nizatidine; Motilium



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Renal Disorder, Rash, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 500 mg, qd
    Administration route: Oral
    Start date: 2012-04-14
    End date: 2012-05-15

Antiviral (Unspecified)
    Dosage: 500 mg, qd
    Administration route: Oral
    Start date: 2012-05-18

Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-06
    End date: 2012-04-09

Antiviral (Unspecified)
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-05-16
    End date: 2012-05-17

Antiviral (Unspecified)
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2012-04-10
    End date: 2012-04-13

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-06

Rebetol
    Dosage: 200 mg, qod
    Administration route: Oral
    Start date: 2012-04-14

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-06
    End date: 2012-04-09

Rebetol
    Dosage: 200mg/every other day
    Administration route: Oral
    Start date: 2012-04-14
    End date: 2012-06-12

Rebetol
    Administration route: Oral
    Start date: 2012-06-13

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-04-10
    End date: 2012-04-13

Telavic
    Administration route: Oral
    Start date: 2012-04-10
    End date: 2012-04-13

Telavic
    Administration route: Oral
    Start date: 2012-05-18
    End date: 2012-06-01

Telavic
    Administration route: Oral
    Start date: 2012-05-16
    End date: 2012-05-17

Telavic
    Administration route: Oral
    Start date: 2012-06-02
    End date: 2012-06-29

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-06
    End date: 2012-04-09

Telavic
    Administration route: Oral
    Start date: 2012-04-14
    End date: 2012-05-15

Other drugs received by patient: Nexium; Gaslon N; Allegra; Coniel; Potassium Chloride; Nexium; Gaslon N; Amaryl; Telmisartan; Dextrose (+) Electrolytes (Unspecified) (+) Sodium Lactate; Amaryl; Hirudoid; Telmisartan; Coniel; Coniel



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Loss of Consciousness, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-27
    End date: 2012-02-02

Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-02-03
    End date: 2012-02-23

Depas
    Dosage: unk, qd
    Administration route: Oral
    Start date: 2012-05-24

Depas
    Dosage: unk
    Administration route: Oral
    Start date: 2012-05-10
    End date: 2012-05-24

Peginterferon Alfa-2B
    Dosage: 0.3 microgram per kilogram, qw
    End date: 2012-03-15

Peginterferon Alfa-2B
    Dosage: 0.96 microgram per kilogram, qw
    Start date: 2012-02-16
    End date: 2012-02-16

Peginterferon Alfa-2B
    Dosage: 0.8 microgram per kilogram, qw
    Start date: 2012-04-05
    End date: 2012-04-26

Peginterferon Alfa-2B
    Dosage: 0.6 microgram per kilogram, unk
    Start date: 2012-05-10
    End date: 2012-05-10

Peginterferon Alfa-2B
    Dosage: 0.32 microgram per kilogram, qw
    Start date: 2012-02-23

Peginterferon Alfa-2B
    Dosage: 0.6 microgram per kilogram, unk
    Start date: 2012-03-22
    End date: 2012-03-29

Peginterferon Alfa-2B
    Dosage: 1.3 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-09

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-02-03
    End date: 2012-02-16

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    End date: 2012-05-31

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-27
    End date: 2012-02-02

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-17
    End date: 2012-02-23

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-02-03
    End date: 2012-02-23

Telavic
    Dosage: unk, qd
    Administration route: Oral
    End date: 2012-03-04

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-27
    End date: 2012-02-02

Telavic
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-04-05
    End date: 2012-04-19

Other drugs received by patient: Urso 250



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: Weight Decreased, Pneumonia, Pruritus, Dyspnoea, Nausea, Pain, Haemoglobin Abnormal, Irritability, Diplopia, Fatigue, Lung Disorder, Dizziness, Asthenia, Decreased Appetite, Influenza

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Rebetol
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Telaprevir
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Other drugs received by patient: Morphine; Synthroid; Oxycodone HCL; Nexium



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Anaemia, Decreased Appetite

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-04-25

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-06-07

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-25
    End date: 2012-06-06

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-05-24
    End date: 2012-06-13

Telavic
    Dosage: 750 mg, qd
    Start date: 2012-06-14
    End date: 2012-07-18

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-25
    End date: 2012-05-23

Other drugs received by patient: Levofloxacin; Allopurinol; Sulfamethoxazole and Trimethoprim; Azunol (Sodium Gualenate); Antebate



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Nausea, Decreased Appetite

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-03-29

Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-30
    End date: 2012-04-16

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-04-16

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-04-16

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-03-29

Telavic
    Administration route: Oral
    Start date: 2012-03-30
    End date: 2012-04-16

Other drugs received by patient: Levocarnitine Hydrochloride; Rabeprazole Sodium; Primperan TAB; L Cartin; Rebamipide



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-01-26
    End date: 2012-07-12

Rebetol
    Dosage: 600 unk, unk
    Administration route: Oral
    Start date: 2012-05-31
    End date: 2012-07-12

Rebetol
    Dosage: 400 unk, unk
    Administration route: Oral
    Start date: 2012-04-26
    End date: 2012-05-30

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-26
    End date: 2012-03-28

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-29

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-26
    End date: 2012-01-28

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-01-28

Other drugs received by patient: Nespo; Clobetasol Propionate; Gasmotin; Etizolam; Celestamine TAB



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-23

Patient:

Reactions: Nausea, Erythema, Neutrophil Count Decreased, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-02-24

Rebetol
    Dosage: 800 mg, qd,cumulative dose:3200 mg
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-24
    End date: 2012-02-28

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-27
    End date: 2012-06-03

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Start date: 2012-03-02
    End date: 2012-03-26

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-24
    End date: 2012-02-28

Other drugs received by patient: Antebate; Loxonin; Valsartan; Lasix; Amino Acids (Unspecified); Norvasc; Lansoprazole; Allegra; Petrolatum; Aspirin; Humalog; Doxazosin Mesylate



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: Anaemia, Blood Creatinine Increased, Decreased Appetite

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-03-23
    End date: 2012-04-22

Peginterferon Alfa-2B
    Dosage: 1.5 microgram per kilogram, qw
    Start date: 2012-05-07

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-23
    End date: 2012-03-29

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-03-30
    End date: 2012-04-04

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-05-07

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-04-05
    End date: 2012-04-22

Telaprevir
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-23
    End date: 2012-04-12

Other drugs received by patient: Primperan TAB; Dogmatyl; Antebate



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Malaise, Vomiting, Nausea, Anaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-04-18

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-05-07

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-05-08
    End date: 2012-05-08

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-05-09
    End date: 2012-05-14

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-05-15

Telavic
    Dosage: 2250 mg, qd,cumulative dose 4500 mg
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-04-25

Telavic
    Dosage: 1000 unk, unk,cumulative dose 4500 mg
    Start date: 2012-06-13
    End date: 2012-07-09

Telavic
    Dosage: 1500 mg, qd,cumulative dose 4500 mg
    Administration route: Oral
    Start date: 2012-04-26
    End date: 2012-06-12

Other drugs received by patient: Motilium; Eurax; Allegra; Clobetasol Propionate; Predonine; Predonine



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-23

Patient:

Reactions: Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-03
    End date: 2012-03-28

Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-22
    End date: 2012-03-02

Antiviral (Unspecified)
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2012-03-29
    End date: 2012-04-11

PEG-Intron
    Dosage: 100mcg/week
    Indication: Hepatitis C
    Start date: 2012-02-22

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-05-02
    End date: 2012-05-16

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-05-17

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-03
    End date: 2012-03-13

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-14
    End date: 2012-04-10

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-22
    End date: 2012-03-02

Telavic
    Dosage: 1000 mg, once
    Administration route: Oral
    Start date: 2012-03-29
    End date: 2012-04-11

Telavic
    Dosage: 2250 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-22
    End date: 2012-03-02

Telavic
    Dosage: 1500 mg, once
    Administration route: Oral
    Start date: 2012-03-03
    End date: 2012-03-28

Other drugs received by patient: Aspirin; Warfarin Potassium; Talion (Bepotastine Besylate); Atarax; Warfarin Potassium; Warfarin Potassium; Nizoral; MK-1459b; Hirudoid; Warfarin Potassium; Candesartan Cilexetil and Hydrochlorothiazide; Aspirin; Fluvastatin; Irbesartan; Locoid; Warfarin Potassium; Nerisona; Nerisona; Nizoral; Warfarin Potassium; Fluvastatin; Talion (Bepotastine Besylate); Norvasc; Xyzal; Antebate; Norvasc; Warfarin Potassium; Norvasc; Locoid; Myser (Difluprednate); Difluprednate; Allopurinol; Warfarin Potassium; Norvasc; Rinderon A



Possible Rebetol side effects in

Reported by a individual with unspecified qualification from Japan on 2012-08-23

Patient:

Reactions: Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-06-01

Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-05-31

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-27

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-06-01

Rebetol
    Administration route: Oral
    Start date: 2012-07-13

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-05-31

Rebetol
    Administration route: Oral
    Start date: 2012-06-01
    End date: 2012-07-12

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-05-31

Telavic
    Administration route: Oral
    Start date: 2012-06-01
    End date: 2012-07-19

Other drugs received by patient: Allopurinol; Acetaminophen; Elpinan; MK-9355; Fulmeta; Feburic; Elpinan; Espo; Feburic; Espo; Fulmeta



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Malaise, Anaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-07-10

Rebetol
    Administration route: Oral
    Start date: 2012-05-15
    End date: 2012-05-28

Rebetol
    Administration route: Oral
    Start date: 2012-04-17

Rebetol
    Administration route: Oral
    Start date: 2012-05-29

Rebetol
    Administration route: Oral
    Start date: 2012-02-22
    End date: 2012-04-16

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-01-30

Rebetol
    Administration route: Oral
    Start date: 2012-01-31
    End date: 2012-02-21

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-01-27

Telavic
    Administration route: Oral
    Start date: 2012-01-28
    End date: 2012-02-13

Telavic
    Administration route: Oral
    Start date: 2012-02-14
    End date: 2012-02-16

Telavic
    Administration route: Oral
    Start date: 2012-02-17
    End date: 2012-04-16



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Haemoglobin Decreased, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-04
    End date: 2012-06-24

Rebetol
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-24

Rebetol
    Administration route: Oral
    Start date: 2012-06-15
    End date: 2012-06-17

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-04
    End date: 2012-06-04

Rebetol
    Administration route: Oral
    Start date: 2012-06-05
    End date: 2012-06-14

Telavic
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-24

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-04
    End date: 2012-06-15

Telavic
    Administration route: Oral
    Start date: 2012-06-16
    End date: 2012-06-17

Other drugs received by patient: Iron Sucrose; Amlodipine Besylate; Enalapril Maleate; Bisoprolol Fumarate; Plavix; Trichlormethiazide; Aspirin; Basen OD; Perycit; Crestor



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Dysgeusia, Anaemia, Malnutrition, Hyperuricaemia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.36mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-03-27

PEG-Intron
    Dosage: 1.5mcg/kg/week
    End date: 2012-05-29

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-27
    End date: 2012-05-28

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-27
    End date: 2012-05-21

Other drugs received by patient: Amlodipine Besylate; NO. 4 A Antipyretic Analgesic; Actos; Vitamedin; Amaryl; TPN Electrolytes IN Plastic Container; Predonine; Naproxen; Malfa; Rabeprazole Sodium; Famotidine



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Malaise, Nausea, Anaemia, Insomnia, Depression, Rash, Constipation, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-22

PEG-Intron
    Dosage: 1.0mcg/kg/week
    Start date: 2012-02-29
    End date: 2012-02-29

PEG-Intron
    Dosage: 0mcg/kg

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-14

Rebetol
    Administration route: Oral
    Start date: 2012-02-15
    End date: 2012-03-07

Rebetol
    Administration route: Oral

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-28

Telavic
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-03-07

Telavic
    Administration route: Oral

Other drugs received by patient: [therapy Unspecified]; [therapy Unspecified]; Milmag; Senna-Mint WAF; [therapy Unspecified]



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Malaise, Blood Urea Increased, Blood Creatinine Increased, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-06-13

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-13

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-13
    End date: 2012-07-03

Telavic
    Administration route: Oral
    Start date: 2012-07-04



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-21

Patient:

Reactions: Weight Decreased, Pneumonia, Pruritus, Nausea, Pyrexia, Headache, Suicidal Ideation, Eating Disorder, Insomnia, Depression, Decreased Appetite, Candidiasis

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Dosage: 180 microgram, qw
    Indication: Hepatitis C
    Start date: 2011-08-19
    End date: 2012-04-18

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-19

Victrelis
    Dosage: 4 df, tid

Victrelis
    Dosage: 40 mg, tid
    Administration route: Oral

Victrelis
    Dosage: 800 mg, tid
    Indication: Hepatitis C
    Start date: 2011-09-16

Victrelis
    Dosage: unk, tid
    Start date: 2011-08-19

Other drugs received by patient: Atarax; Diuretic (Unspecified); Xanax



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-15

Patient:

Reactions: Nausea, Anaemia, Platelet Count Decreased, Hyperuricaemia, Decreased Appetite

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-03-09
    End date: 2012-03-29

Peginterferon Alfa-2B
    Dosage: 1.2 ?g/kg, qw
    Start date: 2012-03-30
    End date: 2012-05-03

Peginterferon Alfa-2B
    Dosage: 0.9 ?g/kg, qw
    Start date: 2012-05-04
    End date: 2012-05-10

Peginterferon Alfa-2B
    Dosage: 1.2 ?g/kg, qw
    Start date: 2012-05-11
    End date: 2012-06-01

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-23

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    End date: 2012-06-01

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-03-19
    End date: 2012-03-22

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-09
    End date: 2012-03-18

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-16
    End date: 2012-05-17

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-09
    End date: 2012-03-15

Telavic
    Dosage: 750 mg, qd
    Administration route: Oral
    Start date: 2012-05-18
    End date: 2012-06-01

Other drugs received by patient: Urso 250; Allopurinol; Caduet; Novamine 15%



Possible Rebetol side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-14

Patient:

Reactions: Haemoglobin Decreased, Renal Impairment, Malaise, Anaemia, Rash, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 80 ?g, qw
    Start date: 2012-03-31

Peginterferon Alfa-2B
    Dosage: 1.5 ?g/kg, qw
    Indication: Hepatitis C
    Start date: 2012-01-26

Peginterferon Alfa-2B
    Dosage: 1.5 microgram per kilogram, qw

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-26
    End date: 2012-02-29

Rebetol
    Dosage: 200 mg, qd
    Start date: 2012-07-12

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-08

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-15
    End date: 2012-03-22

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-03-31
    End date: 2012-04-06

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-01
    End date: 2012-03-07

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-03-24
    End date: 2012-03-30

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-04-19
    End date: 2012-05-16

Rebetol
    Dosage: 400 mg, qd
    Start date: 2012-05-17
    End date: 2012-07-11

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-08
    End date: 2012-03-21

Telavic
    Dosage: 1000 mg, qd
    Administration route: Oral
    Start date: 2012-03-24
    End date: 2012-04-06

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-26
    End date: 2012-03-07

Other drugs received by patient: Clobetasol Propionate; Sedekopan; Nespo; Allopurinol; Nespo; Paxil; Celestamine TAB



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017